Merck & Co. (MRK) Forecast and Sector Context
This forecast assesses the potential trajectory of Merck & Co. (MRK) within the Healthcare sector through 2026. The analysis incorporates available projections to provide a forward-looking perspective on the company. This information is intended to support informed decision-making but should not replace individual due diligence.
Names rising to the top of the screen
The strongest names remain easy to scan without losing the valuation context behind the ranking.
| # | Ticker | Company | AI Score | Price | Change | Market Cap | P/E |
|---|---|---|---|---|---|---|---|
| 1 | MRK | Merck & Co., Inc. | 74 | $144.71 | -1.91% | $357.4B | 114.8 |
| 2 | INCY | Incyte Corporation | 98 | $123.28 | -2.17% | $25.0B | 15.2 |
| 3 | KRYS | Krystal Biotech, Inc. | 98 | $345.55 | -0.73% | $10.2B | 41.8 |
| 4 | EXEL | Exelixis, Inc. | 98 | $56.20 | -2.14% | $14.4B | 17.5 |
| 5 | ETON | Eton Pharmaceuticals, Inc. | 97 | $57.15 | -1.26% | $1.6B | 124.5 |
| 6 | HRMY | Harmony Biosciences Holdings, Inc. | 97 | $41.10 | -1.25% | $2.4B | 13.1 |
| 7 | NHC | National HealthCare Corporation | 97 | $224.92 | -1.02% | $2.2B | — |
| 8 | INSP | Inspire Medical Systems, Inc. | 97 | $73.00 | +7.16% | $2.0B | 14.6 |
| 9 | ARGX | argenx SE | 97 | $984.04 | -1.82% | $61.2B | 36.0 |
| 10 | UTHR | United Therapeutics Corporation | 97 | $503.86 | -0.58% | $21.4B | 16.7 |
| 11 | ATRC | AtriCure, Inc. | 96 | $53.83 | +1.64% | $2.7B | 249.6 |
| 12 | GRDN | Guardian Pharmacy Services, Inc. | 96 | $43.66 | -0.39% | $2.8B | 41.7 |
Where valuation pressure is clustering
Healthcare100%
Key Considerations for Merck & Co. (MRK)
When evaluating forecasts, consider prevailing economic conditions, industry trends, and company-specific developments. Review MRK's performance, financial health, and strategic initiatives. Note that forecasts are inherently uncertain and represent potential future outcomes, not guarantees.
“MoonshotScore rates a US-listed stock 0 to 100 — higher means stronger numbers. Most carry an older nine-factor score; the rest use five sector-relative pillars, re-ranked daily — common stocks and ADRs only. Funds, ETFs, warrants, units, SPACs, preferreds, and notes carry none. It is built for education and deeper due diligence, not financial advice.”
Questions worth resolving before acting on the screen
How accurate are stock forecasts?
Stock forecasts are estimates and not guarantees of future performance. Numerous factors can influence actual results.
What factors can affect MRK's stock price?
Company performance, industry trends, and broader economic conditions can impact MRK's stock price.
Where can I find more information on MRK?
Refer to Merck & Co.'s investor relations page and reputable financial news sources for detailed information.